학술논문
Early picc-line infections in non-neutropenic patients are mainly due to E. colisuggesting that third-generation cephalosporin may be used as a first-line antibiotic therapy
Document Type
Article
Author
Source
Infectious Diseases Now; March 2024, Vol. 54 Issue: 2
Subject
Language
ISSN
26669919
Abstract
•Among Gram-negative bacilli CLABSI, E. coliidentification was the more frequent.•Among Gram-negative bacilli CLABSI, E. coliidentification happened earlier after insertion.•Third-generation cephalosporin may be used as a first-line antibiotic therapy among non-neutropenic patients.